EMAIL THIS PAGE TO A FRIEND

Cancer

Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib.


PMID 25103305

Abstract

We're sorry this abstract is currently not available.